Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $83

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $73 to $83.

byBenzinga Newsdesk

July 30, 2021

1 minute read

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $73 to $83.

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle

By Benzinga Newsdesk

Today, 11:57 PM

Enovis Corporation (NYSE:ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System)

ENOV

JP Morgan Upgrades Sea to Overweight, Announces $70 Price Target

By Benzinga Newsdesk

Today, 11:57 PM

JP Morgan analyst Ranjan Sharma upgrades Sea (NYSE:SE) from Neutral to Overweight and announces $70 price target.

Arista Networks Q2 EPS $2.72 Beats $2.54 Estimate, Sales $707.30M Beat $687.32M Estimate

By Benzinga Newsdesk

Today, 11:57 PM

Arista Networks (NYSE:ANET) reported quarterly earnings of $2.72 per share which beat the analyst consensus estimate of $2.54 by 7.09 percent. This is a 28.91 percent increase over earnings of $2.11 per share from the

ANET

Amazon Discusses Cannabis In Washington D.C.; Will It Actively Push For Legalization And Why?

By Nina Zdinjak

Today, 11:57 PM

In June, corporate giant Amazon (NASDAQ:AMZN) announced it was time to adjust its outdated cannabis policy and told the world it will

AMZN

Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $83

Related Posts

Enovis Receives FDA Approval Of Patient Specific Instrumentation For STAR Ankle

JP Morgan Upgrades Sea to Overweight, Announces $70 Price Target

Arista Networks Q2 EPS $2.72 Beats $2.54 Estimate, Sales $707.30M Beat $687.32M Estimate

Amazon Discusses Cannabis In Washington D.C.; Will It Actively Push For Legalization And Why?